Evidence map›Paper›PMID 21219684›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2011

Reliability of the MODS assay decentralisation process in three health regions in Peru.

A Mendoza, E Castillo, N Gamarra, T Huamán, M Perea, Y Monroi, R Salazar, J Coronel, M Acurio, G Obregón and 4 more

Open access · greenAbstract readEvaluation StudyMulticenter Study
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. The fourth national anti-tuberculosis drug resistance survey in Peru.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2020
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

A MendozaCentro Nacional de Salud Pública, Instituto Nacional de Salud de Perú, Lima, Peru. mendozalberto@hotmail.com
E Castillo
N Gamarra
T Huamán
M Perea
Y Monroi
R Salazar
J Coronel
M Acurio
G Obregón
M Roper
C Bonilla
L Asencios
D A J Moore
Instituto Nacional de Salud · PE

Funding

Peru ICOHRTA Network for AIDS/TB Research TrainingU2RTW007368 · FIC · UNIVERSIDAD PERUANA CAYETANO HEREDIA · PI GOTUZZO, EDUARDO · 2007 to 2011
$1.8M
FIC NIH HHS U2R TW007368Wellcome Trust 078067
6 · The paper itself

Abstract

objectiveTo deliver rapid isoniazid (INH) and rifampicin (RMP) drug susceptibility testing (DST) close to the patient, we designed a decentralisation process for the microscopic observation drug susceptibility (MODS) assay in Peru and evaluated its reliability.

methodsAfter 2 weeks of training, laboratory staff processed ≥ 120 consecutive sputum samples each in three regional laboratories. Samples were processed in parallel with MODS testing at an expert laboratory. Blinded paired results were independently analysed by the Instituto Nacional de Salud (INS) according to pre-determined criteria: concordance for culture, DST against INH and RMP and diagnosis of multidrug-resistant tuberculosis (MDR-TB) ≥ 95%, McNemar's P > 0.05, kappa index (κ) ≥ 0.75 and contamination 1-4%. Sensitivity and specificity for MDR-TB were calculated.

resultsThe accreditation process for Callao (126 samples, 79.4% smear-positive), Lima Sur (n = 130, 84%) and Arequipa (n = 126, 80%) took respectively 94, 97 and 173 days. Pre-determined criteria in all regional laboratories were above expected values. The sensitivity and specificity for detecting MDR-TB in regional laboratories were >95%, except for sensitivity in Lima Sur, which was 91.7%. Contamination was 1.0-2.3%. Mean delay to positive MODS results was 9.9-12.9 days.

conclusionTechnology transfer of MODS was reliable, effective and fast, enabling the INS to accredit regional laboratories swiftly.

Indexed as

Antitubercular AgentsClinical Laboratory TechniquesIsoniazidMicrobial Sensitivity TestsRifampinAccreditationHumansMicroscopyMycobacterium tuberculosisObserver VariationPeruPredictive Value of TestsRegional Health PlanningReproducibility of ResultsSensitivity and SpecificitySputumAntitubercular AgentsIsoniazidRifampin

Identifiers

PMID21219684
PMCPMC3103709
OpenAlexW202563030

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.